At the end of May 2026, KHI’s founder Danielle Drachmann gave the closing keynote at the Veeva Systems R&D and Quality Summit in Copenhagen.
She told the story of her journey from a young mom searching for answers to patient-driven research, academic research and clinical research. Today she is both a co-investigator and a participant in the same clinical trial.
Where the story starts
Seven years earlier, Danielle was searching a Facebook diabetes support group for help with her son’s dangerous low blood sugars. Jacob Petersen, then a VP at Novo Nordisk, reached out and offered to talk with her about her son.
“What I thought would be one phone call turned into one of the most important relationships of my life.”
Danielle Drachmann
Since that first conversation, Danielle and Jacob have published papers, presented at conferences around the world and founded Ketotic Hypoglycemia International together.
Return on Engagement
In the keynote Danielle introduced Return on Engagement (ROE), her idea for how real partnership with patients creates value in research. Veeva Systems described it as “a more meaningful path to partnership and a faster route to successful clinical trial outcomes.” You can find her article on Return on Engagement on our research page.
After the summit, HuffPost Italia interviewed Danielle about how lived experience led her into science and patient advocacy. The article is in Italian and is listed on our press page.
Thank you to Veeva Systems for the invitation, and to Nitsa Zuppas, Gurpreet Kaur, Chris Moore and Jo Taylor.
From the day







Danielle shared this on LinkedIn. Read her post on LinkedIn.

